Trademark Overview
On Friday, January 23, 2026, a trademark application was filed for TERRESTRIAL BIO with the United States Patent and Trademark Office. The USPTO has given the TERRESTRIAL BIO trademark a serial number of 99611841. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, June 1, 2026. This trademark is owned by Vaxess Technologies, Inc.. The TERRESTRIAL BIO trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of a wide range of pharmaceuticals, and applicators therefor; drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of pharmaceuticals, namely, vaccines, anti-viral therapies, immunotherapies, hormones for medical purposes, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, and fertility diseases, and applicators therefor; patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of vitamins and nutritional supplements, and applicators therefor
